Peptide chain polypeptide
Author
Throughout the environment of China's medical reform, the degree of marketization of medical health has gradually improved, and naturally it has become the focus of “smart†industrial investment funds. Nowadays, the positioning of public medical systems is gradually clear, and non-public is injected as more capital. The market for systemic medical care is still “turbulentâ€, and how to obtain the affirmation of market operation results has become the center of the capital’s efforts.
The competitiveness of the medical industry is not only reflected in the consumption of the population. We look at the recent hot spots of investment in the trend of aging, chronic diseases or cancer, and dilute some of the scalability needs, such as test-tube babies, private dentistry. , doctor group.
Nowadays, the trend of investment in heavy-asset medical services is mainly based on investment hospitals. Among them, the most characteristic of capital operation is the characteristics of regional, branding and incubator.
The transformation of public hospitals has also opened up a market for the capital side and has become a major form of rapid access to quality standards. Middle-level hospitals tend to be the first echelon of transformation, and the high-end medical service industry will also be in the first-tier cities in China. enter.
In the traditional medical industry chain, pharmaceutical companies, hospitals, patients, medical insurance, and medical equipment are the main participants in the diagnosis and treatment services received by patients in hospitals, and the value and relevance of relevant stakeholders. Equipment, doctor resources, and the data produced are at an absolute high.
"Peptide Chain" in interviews with multi-party medical investors, there is a common pain point is also their scruples, "the medical industry has its own objective development law, but also subject to strict policy supervision, if you want to rely on capital to ripen The market is an unrealistic idea."
If we want to mature the medical service market, policy-oriented and industry-wide competition will become a key point. Without these prerequisites, it will be difficult to form an advantage in the competition, and the medical market that has always been “occluded†is necessary. Gradually evolved to cater to the development of the times.
Medical services must be driven by technology, and the provider of technology is currently only about 3.5 million doctors. So in 2014, the introduction of “doctor group†quickly gained attention in the capital market. It has also become better and more market-oriented under the strong promotion of national policies. As a supplement to the medical service market, it has also achieved considerable results under the efforts of many parties.
Another reason for doctors to start their own businesses is that the government has introduced a large number of policies to “incite†social capital to invest in the health industry and promote the development of non-public medical institutions. It is difficult for doctors to open a small clinic at their own discretion. It is bigger and stronger, but it is necessary to make more market supplements by the power of capital. However, the power of a single doctor is really “human and thin†when playing against capital, and the doctor group can develop as an independent institution.
The services of the medical group can be summarized into two categories, one is 2B business, providing services for R&D institutions and medical institutions, such as CRO, CMO and hospital information; the other is 2C business, providing medical and medical examination services for individuals. The service is just in need, and the vertical track of each subdivided medical service is more favored by capital.
Faced with the confusion of the industrial investment of the doctor group, Huang, who shared the investment co-founder, pointed out: “There are many pain points in the existing system, the urgent need to reconstruct the production factors, the increasingly favorable policy environment, and the gradual improvement of the commercial system are the existing development opportunities of the doctor group. The current medical service system must stir the production factors and optimize the configuration."
The rise of the medical team is focused on the core elements of the flow and radiant value of quality doctors. In the current era, the doctor community is gradually turning into a core scarce resource, a leader of change and an important participant and a potential future integrator. .
At the same time, the success of the doctor group model in the United States, Singapore, and Taiwan is based on the full flow of medical talent and the high level of activity of private institutions.
At present, the doctors who have jumped out of the system are still a minority. Once they leave the aura of the famous hospital, the transition from "medical people" to "marketers" will face many risks. Nowadays, the doctors' group model in the system is single and has limited energy.
However, the group of doctors outside the system is driven by capital under the pressure of not being able to satisfy the valuation. When it opens a physical medical institution and abandons the light asset development path and shifts into the field of heavy assets, it will also face greater institutional operational pressure and also change. The original set business model.
From the perspective of investors, how to use capital to enhance its development depth, highlighting the core competitiveness of the doctors group and realizing the value of doctors' groups has become a great pain point.
Most doctor groups that are rushing in the market have no head effect and no direction of business model evolution. Therefore, it is necessary to follow the traditional market operation routines, consolidate the technical level, and find a suitable business model is short-term. The goal is also waiting for a more planned, market-oriented market.
However, the medical and health industry as a weak cycle industry, in the face of uncertain economic prospects, economic downturn, medical services as a need and more capital as a safe haven to avoid the cold winter, the lower risk is relatively small, exit is relatively easy, but also a good layout Through medical services, the entire bottom layer of the health care industry is built, and medicines and equipment are inseparable from medical service scenarios. Naturally, it is also the driving force for more capital cross-border investment in the medical industry.
It is the current choice of medical practice to fill the gap in public medical institutions. However, private medical institutions still need to analyze what gaps can be filled before making strategic decisions, especially if they can meet the talent supply. There are serious shortcomings, such gaps are not suitable for private institutions to undertake and supplement, which requires investors to pay careful attention.
Our company mainly processes and exports Ginger, which is processed and sold throughout the year. The specifications are: 50g, 150g, 200g, 250g, 300g, 350g.The packages are calcium plastic boxes, cartons and mesh bags.Products are exported to Europe, the United States, South Korea, Malaysia, the Middle East and other countries and regions.The company relies on the good prestige and the excellent product quality has won the general customer the high praise, hoped has the export order the customer please to relate with us.In order to establish long-term business relations, mutual benefit and common development.
Fresh Ginger,Fresh Young Ginger,Fresh Mature Ginger,Bulk Fresh Ginger
Jining Sunagro Trade Co., Ltd. , https://www.sunagro-food.com